AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
TRASTUZUMAB in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| HERCEPTIN POWDER/INJECTABLE; INJECTION | 2014/9.7/4830 | ROCHE PRODUCTS (PTY) LTD | active | 31 Dec 2027 |
| OGIVRI INJECTABLE; IV (INFUSION) | 2018/9.7/5680 | BIOSIMILARS NEWCO LIMITED | active | 31 Dec 2027 |
| OGIVRI POWDER/INJECTABLE; INJECTION | 2021/9.7/6090 | BIOSIMILARS NEWCO LIMITED | active | 31 Dec 2027 |
| HERCEPTIN SC INJECTABLE; INJECTION | 2017/9.7/5512 | ROCHE PRODUCTS (PTY) LTD | active | 31 Dec 2027 |
TRASTUZUMAB — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing TRASTUZUMAB, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track TRASTUZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.